Value of Immunohistochemistry in Staging T1 Urothelial Bladder Carcinoma

By Mhawech P.   Iselin C.   Pelte M.-F.  

European Urology, Vol. 42, Iss. 5, 2002-11 ,pp. : 459-463

Elsevier

Access to resources Recommend Favorite

Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guerin therapy

By Peyromaure M.   Weibing S.   Sebe P.   Verpillat P.   Toublanc M.   Dauge M.-C.   Boccon-Gibod L.   Ravery V.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 409-413

Elsevier

Access to resources Recommend Favorite

Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder

By Bol M.G.W.   Baak J.P.A.   Rep S.   Marx W.L.   Kruse A.J.   Bos S.D.   Kisman O.   Voorhorst F.J.  

Urology, Vol. 60, Iss. 6, 2002-12 ,pp. : 1124-1130

Elsevier

Access to resources Recommend Favorite

Prognostic value of p53, Ki-67, microstaging and microvessel density in pT1G3 bladder tumors: Creation of risk groups for progression

By Queipo-Zaragoza José Antonio   Ruiz-Cerda José Luíz   Vera-Donoso Cesar David   Vera-Sempere Francisco   Budia-Alba Alberto   Jimenez-Cruz Juan Fernando  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 4, 2007-09 ,pp. : 283-289

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Value of MCM2 Immunoreactivity in Stage T1 Transitional Cell Carcinoma of the Bladder

By Kruger S.   Thorns C.   Stocker W.   Muller-Kunert E.   Bohle A.   Feller A.C.  

European Urology, Vol. 43, Iss. 2, 2003-02 ,pp. : 138-145

Elsevier

Access to resources Recommend Favorite